Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakari Kauppinen

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Non-Coding RNA|September 3, 2020
Long Non-Coding RNAs in Liver Cancer and Nonalcoholic SteatohepatitisShizuka Uchida, Sakari Kauppinen
Expert Opinion on Biological Therapy|December 18, 2007
MicroRNAs as targets for antisense-based therapeuticsJan Stenvang, Sakari Kauppinen
The Journal of Cell Biology|October 31, 2012
Discovering the first microRNA-targeted drugMorten Lindow, Sakari Kauppinen
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Detection of siRNAs and miRNAsSakari Kauppinen, Zoltán Havelda
EMBO Molecular Medicine|June 18, 2014
Development of microRNA therapeutics is coming of ageEva van Rooij, Sakari Kauppinen
Neuromolecular Medicine|June 19, 2009
microRNAs in CNS disordersJannet Kocerha, Sakari Kauppinen, Claes Wahlestedt
Drug Discovery Today. Technologies|July 2, 2014
Locked nucleic acid (LNA): High affinity targeting of RNA for diagnostics and therapeuticsSakari Kauppinen, Birte Vester, Jesper Wengel
Biochemical Society Transactions|November 22, 2008
Targeting of microRNAs for therapeuticsJan Stenvang, Morten Lindow, Sakari Kauppinen
Cancer Research|January 17, 2009
MicroRNA silencing in primates: towards development of novel therapeuticsAndreas Petri, Morten Lindow, Sakari Kauppinen
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
Development of siRNA Therapeutics for the Treatment of Liver DiseasesAnja Holm, Marianne Bengtson Løvendorf, Sakari Kauppinen
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Non-Coding RNA|September 3, 2020
Long Non-Coding RNAs in Liver Cancer and Nonalcoholic SteatohepatitisShizuka Uchida, Sakari Kauppinen
Expert Opinion on Biological Therapy|December 18, 2007
MicroRNAs as targets for antisense-based therapeuticsJan Stenvang, Sakari Kauppinen
The Journal of Cell Biology|October 31, 2012
Discovering the first microRNA-targeted drugMorten Lindow, Sakari Kauppinen
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Detection of siRNAs and miRNAsSakari Kauppinen, Zoltán Havelda
EMBO Molecular Medicine|June 18, 2014
Development of microRNA therapeutics is coming of ageEva van Rooij, Sakari Kauppinen
Neuromolecular Medicine|June 19, 2009
microRNAs in CNS disordersJannet Kocerha, Sakari Kauppinen, Claes Wahlestedt
Drug Discovery Today. Technologies|July 2, 2014
Locked nucleic acid (LNA): High affinity targeting of RNA for diagnostics and therapeuticsSakari Kauppinen, Birte Vester, Jesper Wengel
Biochemical Society Transactions|November 22, 2008
Targeting of microRNAs for therapeuticsJan Stenvang, Morten Lindow, Sakari Kauppinen
Cancer Research|January 17, 2009
MicroRNA silencing in primates: towards development of novel therapeuticsAndreas Petri, Morten Lindow, Sakari Kauppinen
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
Development of siRNA Therapeutics for the Treatment of Liver DiseasesAnja Holm, Marianne Bengtson Løvendorf, Sakari Kauppinen
Pageof 10